(4-Methoxy-6-methylpyridin-2-yl)methanol, 95+%, 1g

Matrine>98.0%(GC)(T)200mg

Benzamide, 4-[(9-cyclopentyl-7,7-difluoro-6,7,8,9-tetrahydro-5-methyl-6-oxo-5H-pyrimido[4,5-b][1,4]diazepin-2-yl)amino]-2-fluoro-5-methoxy-N-(1-methyl-4-piperidinyl)-, 97%, 100mg

1-Ethyl-3-methyl-imidazolium-, méthanesulfonate, min 99%, 100 g, emballage en verre

N-(9-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-6-yl)benzamide, 98%, 250mg

tert-butyl N-({1H,4H,5H,7H-pyrano[3,4-c]pyrazol-7-yl}methyl)carbamate, 97%, 100mg

Rebastinib, 99.91%, 5mg

N-Boc-2-Propargyl-D-glycine, 95.0%, 10g

Methyl 2-amino-5-fluoro-3-nitrobenzoate, 95.0%, 1g

Methyl 4-(hydroxymethyl)-3-methoxybenzoate, 95.0%, 100mg

tert-Butyl 4-cyano-4-(p-tolylamino)piperidine-1-carboxylate, 95%, 2g

2-Hydroxymethyl-1-methyl-5-nitroimidazole>98.0%(GC)(T)5g

Pot en verre DURAN®, 75 ml, , 60 mm, Hauteur, 40 mm, 1 Pièce